Selective Smurf1 E3 ligase inhibitors that prevent transthiolation
Chuong, P.; Statsyuk, A. V.
Show abstract
Smurf1 is a HECT E3 ligase that is genetically micro-duplicated in human patients and is associated with osteoporosis. Smurf1-/- mice on the other hand show an increase in bone density as they age, while being viable and fertile. Therefore, Smurf1 is a promising drug target to treat osteoporosis. This paper reports the discovery, synthesis, and biochemical characterization of highly selective Smurf1 inhibitors. We show that these compounds inhibit the catalytic HECT domain of Smurf1 with 500 nM IC50, but they do not inhibit closely related Smurf2 ligase, which is 80% identical to Smurf1. We show that Smurf1 inhibitors act by preventing the trans-thiolation reaction between Smurf1 and E2[~]Ub thioesters. Our preliminary studies show that the C-lobe of Smurf1 alone does not contribute to the observed high selectivity of Smurf1 inhibitors.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Characterization of novel competitive inhibitors of P. falciparum cGMP-dependent protein kinase 94%
- Efficient chemical and enzymatic syntheses of FAD nucleobase analogues and their analysis as enzyme cofactors 94%
- CYP154C5 regioselectivity in steroid hydroxylation explored by substrate and protein engineering 93%
Similar papers in this journal
Similar papers in this journal
- Optimization of pyrazolopyrimidines lead to the identification of a highly selective casein kinase 2 inhibitor 95%
- Development of pyrazolopyrimidine based macrocyclic kinase inhibitors targeting AAK1 95%
- Modulation of endogenous opioid signaling by inhibitors of puromycin sensitive aminopeptidase 95%
Similar papers in this journal
- Repurposing of the RIPK1 selective benzooxazepin-4-one scaffold for the development of a type-III LIMK1/2 inhibitor 94%
- Rational development of a small-molecule activator of CK1γ2 that decreases C99 and beta-amyloid levels 94%
- Synthesis and Characterization of ULK1/2 Kinase Inhibitors that Inhibit Autophagy and Upregulate Expression of Major Histocompatibility Complex I for the Treatment of Non-Small Cell Lung Cancer 94%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.